205 related articles for article (PubMed ID: 32783473)
1. Use of the Interoperable Artificial Pancreas System for Type 1 Diabetes Management During Psychological Stress.
Pinsker JE; Deshpande S; McCrady-Spitzer S; Church MM; Kaur RJ; Perez J; Desjardins D; Piper M; Reid C; Doyle FJ; Kudva YC; Dassau E
J Diabetes Sci Technol; 2021 Jan; 15(1):184-185. PubMed ID: 32783473
[No Abstract] [Full Text] [Related]
2. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
[TBL] [Abstract][Full Text] [Related]
3. [What is the current state of the artificial pancreas in diabetes care?].
Dimou M; Laimer M; Stettler C; Bally L
Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
[TBL] [Abstract][Full Text] [Related]
4. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
[TBL] [Abstract][Full Text] [Related]
5. Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency.
Klonoff DC; Shang T; Zhang J
J Diabetes Sci Technol; 2021 Mar; 15(2):211-213. PubMed ID: 33650456
[No Abstract] [Full Text] [Related]
6. Development and Future of Automated Insulin Delivery (AID) Systems.
Garg SK; McVean JJ
Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322
[No Abstract] [Full Text] [Related]
7. Open-source automated insulin delivery in type 1 diabetes-the evidence is out there.
Hussain S; Lal RA; Braune K
Lancet Diabetes Endocrinol; 2022 Dec; 10(12):835-836. PubMed ID: 36244346
[No Abstract] [Full Text] [Related]
8. Do-It-Yourself Automated Insulin Delivery: A Position Statement.
; Halperin IJ; Chambers A; Covello L; Farnsworth K; Morrison AE; Schuklenk U; Witteman HO; Senior P; ; Bajaj HS; Barnes T; Gilbert J; Honshorst K; Kim J; Lewis J; MacDonald B; Mackay D; Mansell K; Rabi D; Senior P; Sherifali D
Can J Diabetes; 2023 Jul; 47(5):381-388. PubMed ID: 37532365
[No Abstract] [Full Text] [Related]
9. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
10. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data.
Müller-Korbsch M; Frühwald L; Kietaibl A
J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931
[No Abstract] [Full Text] [Related]
11. Quantifying Input Behaviors That Influence Clinical Outcomes in Diabetes and Other Chronic Illnesses.
Lewis DM
J Diabetes Sci Technol; 2022 May; 16(3):786-787. PubMed ID: 34971322
[No Abstract] [Full Text] [Related]
12. Type 1 diabetes: NICE recommends new "artificial pancreas" technology.
Iacobucci G
BMJ; 2023 Jan; 380():55. PubMed ID: 36627118
[No Abstract] [Full Text] [Related]
13. Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.
Pinsker JE; Laguna Sanz AJ; Lee JB; Church MM; Andre C; Lindsey LE; Doyle FJ; Dassau E
Diabetes Technol Ther; 2018 Jul; 20(7):455-464. PubMed ID: 29958023
[TBL] [Abstract][Full Text] [Related]
14. Large Treatment Effects With Automated Insulin Delivery System.
Slomski A
JAMA; 2022 Oct; 328(16):1581-1582. PubMed ID: 36282258
[No Abstract] [Full Text] [Related]
15. Emerging Technologies for Diabetes Care.
Bailey TS; Walsh J; Stone JY
Diabetes Technol Ther; 2018 Jun; 20(S2):S278-S284. PubMed ID: 29916738
[TBL] [Abstract][Full Text] [Related]
16. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
17. Who needs an artificial pancreas? (？).
Winikoff J; Drexler A
J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
[TBL] [Abstract][Full Text] [Related]
18. A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus.
Sachdeva P; M AR; Shukla R; Sahani A
J Med Eng Technol; 2022 Nov; 46(8):693-702. PubMed ID: 35801984
[TBL] [Abstract][Full Text] [Related]
19. Automated blood glucose control in type 1 diabetes: A review of progress and challenges.
Bertachi A; Ramkissoon CM; Bondia J; Vehí J
Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):172-181. PubMed ID: 29279252
[TBL] [Abstract][Full Text] [Related]
20. Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes.
Harris E
JAMA; 2023 Apr; 329(15):1249. PubMed ID: 36988977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
